{"url_path":"/sec/syk/8-k/2026-06-26/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 OTHER EVENTS","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/310764/0000310764-26-000041-index.html","accession_number":"0000310764-26-000041","cik":"0000310764","ticker":"SYK","issuer_name":"STRYKER CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/310764/0000310764-26-000041-index.html","primary_entity_key":"0000310764","primary_entity_name":"STRYKER CORP"},"word_count":524,"has_tables":true,"body_markdown":"ITEM 8.01OTHER EVENTS\n\nSegment Reporting Changes\n\nIn the first quarter 2026 Stryker Corporation (\"we\" or the \"Company\") announced a change in our organizational structure. Our new Ortho Tech business combines the orthopaedic instruments portfolio from our Instruments business with the Mako and enabling technologies portfolio from our Other Orthopaedics business. By bringing Mako, power tools, cutting accessories, enabling technologies and the teams behind these products together under one business, we are simplifying the customer experience and striving to increase our speed to market through focused innovation.\n\nFollowing this reorganization we will continue to have two business segments - (i) MedSurg and Neurotechnology and (ii) Orthopaedics, each of which comprise a reportable segment.\n\nThe rules of the Securities and Exchange Commission require that when a registrant prepares, on or after the date a registrant reports an accounting change such as the segment changes noted above, a new registration, proxy, or information statement (or amends a previously filed registration, proxy, or information statement) that includes or incorporates by reference financial statements, the registrant must recast the prior period financial statements included or incorporated by reference in the registration, proxy, or information statement to reflect these types of changes. Accordingly, the Company is filing this Form 8-K to recast our consolidated financial statements for each of the three years in the period ended December 31, 2025, to reflect the changes in segment reporting as described above. The updates do not represent a restatement of previously issued financial statements. The recast information of Items contained in the 2025 Form 10-K (the \"2025 Annual Report\") is presented in Exhibit 99.1 to this Form 8-K, which is incorporated herein by reference.\n\nThe information included in this Form 8-K is presented for informational purposes only in connection with the segment reporting changes described above and does not amend or restate our audited consolidated financial statements, which were included in the 2025 Annual Report. This filing does not reflect any subsequent information or events occurring after we filed the 2025 Annual Report other than adjustments to reflect the updated segment information in conjunction with the change in business structure previously described. The recast included in Exhibit 99.1 to this Form 8-K reflects changes to the 2025 Annual Report as a result of the change in business structure. Without limitation of the foregoing, this filing does not purport to update Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the 2025 Annual Report for any information, uncertainties, transactions, risks, events or trends occurring, or known to management. More current information is contained in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026 (the “Quarterly Report on Form 10-Q”) and other filings with the Securities and Exchange Commission. This Form 8-K should be read in conjunction with the 2025 Annual Report and the Quarterly Report on Form 10-Q and other filings filed by us with the Securities and Exchange Commission. The Quarterly Report on Form 10-Q and other filings contain important information regarding events, developments and updates to certain expectations of the Company that have occurred since the filing of the 2025 Annual Report."}